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Summary
The MtrCDE multidrug pump, from Neisseria gonor-
rhoeae, is assembled from the inner and outer mem-
brane proteins MtrD and MtrE, which are connected
by the periplasmic membrane fusion protein MtrC.
Although it is clear that MtrD delivers drugs to the
channel of MtrE, it remains unclear how drug delivery
and channel opening are connected. We used a van-
comycin sensitivity assay to test for opening of the
MtrE channel. Cells expressing MtrE or MtrE-E434K
were insensitive to vancomycin; but became moder-
ately and highly sensitive to vancomycin respectively,
when coexpressed with MtrC, suggesting that the MtrE
channel opening requires MtrC binding and is energy-
independent. Cells expressing wild-type MtrD, in an
MtrCE background, were vancomycin-insensitive, but
moderately sensitive in an MtrCE-E434K background.
The mutation of residues involved in proton trans-
location inactivated MtrD and abolished drug efflux,
rendered both MtrE and MtrE-E434K vancomycin-
insensitive; imply that the pump–component interac-
tions are preserved, and that the complex is stable in
the absence of proton flux, thus sealing the open end
of MtrE. Following the energy-dependent dissociation
of the tripartite complex, the MtrE channel is able to
reseal, while MtrE-E434K is unable to do so, resulting
in the vancomycin-sensitive phenotype. Thus, our
findings suggest that opening of the OMP via interac-
tion with the MFP is energy-independent, while both
drug export and complex dissociation require active
proton flux.
Introduction
Gram-negative bacteria utilize homologous tripartite-
transport systems to pump cytotoxic compounds, including
antibiotics and metals (Pietras et al., 2008; Blair and
Piddock, 2009; Misra and Bavro, 2009; Su et al., 2011a)
from the cell. These tripartite pumps are composed of inner
(IMP) and outer (OMP) membrane proteins, which are
connected by a periplasmic membrane fusion protein
(MFP). There are 3D structures for all of the individual
components: for example, in the case of the AcrABTolC
multidrug pump and CusABC copper pump from
Escherichia coli, the structure of the IMPs AcrB (Murakami
et al., 2002; Yu et al., 2003) and CusA (Long et al., 2010),
and of their cognate MFPs, AcrA (Mikolosko et al., 2006)
and CusB (Su et al., 2009), and OMPs, TolC (Koronakis
et al., 2000) and CusC (Kulathila et al., 2011), have been
determined. While the different tripartite pumps use struc-
turally related MFPs and OMPs they use at least three
different types of IMPs: predominantly proton-driven trans-
porters, belonging to the RND and MF family, but some
also use ABC transporters. For example, the AcrABTolC
multidrug pump and CusABC copper pump utilize the RND
transporters AcrB (Murakami et al., 2002) and CusA (Long
et al., 2010), respectively, while the E. coli EmrABTolC and
MacABTolC antibiotic pumps utilizes the MF and ABC
transporters EmrB (Lomovskaya and Lewis, 1992) and
MacB (Kobayashi et al., 2001) respectively. In addition, the
OMPs of the TolC family also participate in Type I secretion
systems for protein toxins, such as the HlyBDTolC pump
that secretes a-haemolysin (HlyA) (Holland et al., 2005).
IMPs belonging to the RND family, represented by AcrB
and CusA, as well as the OMPs, such as TolC and CusC,
function as trimeric assemblies. There is evidence that
the periplasmic domains of AcrB and TolC contact one
another, while AcrA stabilizes this interaction by binding
across these proteins (Tikhonova and Zgurskaya, 2004;
Touzé et al., 2004; Tamura et al., 2005). Cross-linking
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studies indicate that the a-helical coiled-coil hairpin of
AcrA fits into intra-protomer grooves of the open state of
TolC, while its b-/lipoyl domains interact with the periplas-
mic domain of AcrB, at the interface between adjacent
subunits (Lobedanz et al., 2007; Symmons et al., 2009).
However, recent studies indicate that AcrA has a pro-
pensity to form dimers, which can then assemble into
hexamers (Tikhonova et al., 2011; Xu et al., 2011). These
findings have led to two different models for the assembly:
one in which the AcrA dimers bind to a pair of sites,
presumably the intra- and inter-protomer groves, on the
surface of TolC and AcrB, strengthening their interaction
with one another (Tikhonova et al., 2011); while in the
other, the dimers form a hexameric channel, interconnect-
ing AcrB to TolC (Xu et al., 2011). Our previous studies of
the MtrCDE pump from Neisseria gonorrhoeae also
revealed that the MFP MtrC forms dimers that assemble
into a hexameric channel, which has an aperture sufficient
to accommodate the MtrE trimer (Janganan et al.,
2011a,b). Cross-linking the MtrC dimers in the presence
of MtrE stabilized an MtrC : MtrE assembly with a stoichi-
ometry of 6:3. However, we found that the a-helical
hairpin domain of MtrC could be cross-linked to the
a-helical domain of MtrE, consistent with it binding to
intra- and inter-protomer grooves on the surface of
trimeric MtrE (Janganan et al., 2011b). Since we also
found that trimeric MtrD interacts with trimeric MtrE, albeit
weakly, our findings indicate that the MtrCDE pump is
assembled with an MtrD : MtrC : MtrE stoichiometry of
3:6:3, in which MtrD and MtrE are held together by MtrC
binding across their surfaces. Importantly, recent crystal-
lographic studies of the CusAB complex also revealed an
assembly with a stoichiometry of 6:3 (Su et al., 2011b).
Despite the wealth of structural data some fundamental
questions on the function of bacterial tripartite multidrug
pumps remain unanswered, in particular the role of the
membrane fusion proteins in energy transduction between
the inner and outer membrane proteins. Previously we
isolated a mutant of mtrE, encoding an E434K derivative,
which exhibits a higher propensity of opening; however, it
only does so in response to the binding of MtrC (Janganan
et al., 2011a). Consistent with MtrC binding to the intra-
and inter-protomer grooves of MtrE, mutations in these
grooves hindered pump function. It was possible to intro-
duce cysteines into the MtrE grooves and the MtrC hairpin
that could be cross-linked, locking the pump in the closed-
channel state (Janganan et al., 2011b). However, there
remains the fundamental question of the role of MtrD in
controlling the activity of the pump. Herein, we present
evidence that a non-functional MtrD, with charged residues
in the trans-membrane (TM) helices mutated to inhibit
proton translocation, blocks the MtrE channel because it
fails to dissociate from the tripartite complex. This is the first
report that the pumping of drugs into the channel of the
OMP and its dissociation from the IMP both require energy
derived from proton translocation through the IMP.
Results
Full-length MtrC is required to induce opening of the
MtrE channel
The MtrE open-state channel can be detected by determin-
ing the susceptibility of cells to vancomycin, which only
enters cells by passive diffusion very slowly due to its large
size, but can gain entry readily through an open OMP
(Bavro et al., 2008; Janganan et al., 2011a,b). Cells
expressing MtrE or its E434K derivative are insensitive to
vancomycin; however, when expressed with MtrC, the
cells expressing MtrE become moderately susceptible to
vancomycin, while those expressing MtrE E434K become
highly susceptible to (discs impregnated with 30 mg of)
vancomycin and fail to grow (Fig. 1; Table 1). This behav-
iour indicates that MtrC induces opening of the MtrE
channel and presumably stabilizes the fully open-channel
state of MtrE E434K. Previously we established that the
purified N-terminal a-helical hairpin domain, incorporating
residues 103–183, of MtrC, retains a-helical structure and
binds to MtrE and its E434K derivative (Janganan et al.,
2011a,b). Indeed, isothermal microcalorimetry (ITC)
studies revealed that while NT-MtrC binds to MtrE with a Kd
of 9.8 mM, the hairpin binds to MtrE and MtrE E434K with a
Kd of 2.2 mM and 0.13 mM respectively (Janganan et al.,
2011a,b). Considering that MtrE binds the hairpin with
relatively high affinity, we sought to determine if binding of
the hairpin would be sufficient to induce opening of the
MtrE channel. To test whether the hairpin could induce
opening of the MtrE channel, we expressed it with a gIII
signal sequence that targeted it to the periplasm (see
Experimental procedures). Cells expressing the hairpin
with MtrE or MtrE E434K were insensitive to vancomycin,
indicating that it is incapable of inducing channel opening
(Table 1). As a control, we tested and found that cells
expressing NT-MtrC, targeted to the periplasm with a gIII
signal sequence, were sensitive to vancomycin and failed
to grow (Table 1). Thus, suggesting that the lipoyl, b-barrel
and/or MP domains of MtrC, which interact with MtrD, relay
conformational changes in MtrD to MtrE, inducing opening
of its channel. Considering this behaviour we also tested
the effect of expressing MtrD with MtrCE and MtrCE
E434K, revealing that the cells were, insensitive and only
moderately sensitive to (discs impregnated with 30 mg of)
vancomycin respectively (Table 1). Furthermore, strains
expressing pACYC-mtrCDE, and control strains with the
pACYC vector, had an MIC of 512 mg ml-1, while cells
expressing pACYC-mtrCDE-E434K and pACYC-mtrCE-
E434K had MICs of 64 mg ml-1 and 16 mg ml-1 respectively
(Janganan et al., 2011a). It is not surprising then that cells
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expressing mtrCDE grew without any apparent inhibition
around a disc impregnated with 30 mg of vancomycin, while
the cells expressing mtrCDE434K had a moderate zone of
inhibition, and those expressing mtrCE434K failed to grow
to any extent (Table 1). When compared with the suscep-
tibility of cells expressing MtrCE and MtrCE E434K to
vancomycin, these data indicate that MtrD retards vanco-
mycin entry, presumably by either re-closing the MtrE
channel and/or the occlusion of the periplasmic end of MtrE
during complex formation.
We sought to provide further evidence that vancomycin
enters the cells through open MtrE. Large positively
charged ions, such as hexamminecobalt (III) chloride
(HC), have been shown to block the TolC channel via
co-ordination with the ‘second selectivity’ gate residues
Asp371 and Asp374, which form two concentric circles of
negative charges in the inner cavity of TolC (Andersen
et al., 2002b). Indeed TolC has been successfully crystal-
lized in complex with HC (Higgings et al., 2004) and the
binding has been shown to block the channel in electro-
physiological studies (Andersen et al., 2002a,b). The
affinity of the binding has been estimated to be in the
range ~ 20 nM from ITC measurements (Higgins et al.,
2004). The TolC channel is effectively sealed for transport
unless the Asp-ring is broken, which is suggested to be
one of the roles of the MFP (Bavro et al., 2008). Hexam-
mine cobalt stabilizes the Asp-ring, and hence renders the
channel non-conductive to larger cargo. Using compara-
tive sequence analysis and homology modelling studies
of the MtrE channel (Janganan et al., 2011a), here we
demonstrate that the Asp371 and Asp374 are conserved
in MtrE, and the corresponding residues (Asp422 and
Asp425 respectively) are exposed to the internal channel
cavity, thus likely forming a similar arrangement to that in
TolC (Fig. 2A). Hence, we capitalized on this to test
whether blockage of the MtrE channel with HC would also
result in a lowered sensitivity to vancomycin, as the latter
is using the channel for cell entry. A growth curve analysis,
using a series of increasing HC concentrations, revealed
that concentrations above 50 mM were inhibitory for cell
growth: in subsequent experiments 25 mM HC was used,
which did not significantly inhibit cell growth (Fig. 2B).
Consistent with HC blocking the MtrE channel, 25 mM HC
caused a clear and significant decrease in the sensitivity
of the cells, expressing both MtrC along with MtrE E434K,
to 6.4 mg ml-1 vancomycin (Fig. 2B; left graph). Indeed, we
found that the inclusion of 25 mM hexammine cobalt
caused an increase in the MIC for vancomycin for cells
expressing MtrCE E434K from 16 mg ml-1 to 64 mg ml-1. It
was notable that HC appeared more efficient at blocking
the entry of vancomycin into cells expressing MtrC and
MtrE E434K with MtrD (Fig. 2B; right graph and bar chart).
Fig. 1. An E434K derivative of MtrE can be used to detect
channel opening. Disc-diffusion assays were used to determine if
KAM3(DE3) E. coli cells expressing mtrCDE genes and mutants
were susceptible to vancomycin, which can be used as a marker of
whether the OMP MtrE is open or closed, since it is too large to
readily diffuse across the OM but can enter cells via an open OMP.
A set of plates showing the disc-diffusion assays for cells
expressing (i) MtrC and MtrE, (ii) MtrE E434K and (iii) MtrC and
MtrE E434K. It is notable that cells expressing MtrE E434K alone
were insensitive to vancomycin, MtrC/MtrE were moderately
sensitive to vancomycin, and MtrC/MtrE E434K failed to grow in the
presence of vancomycin. Disc-diffusion assays were performed in
triplicate, generally assaying for growth around discs impregnated
with the following antibiotics: vancomycin (Van; 30 mg), nafcillin
(Naf; 1 mg), tetracycline (Tet; 30 mg), erythromycin (Ery; 10 mg) and
novobiocin (Nov; 5 mg).
Table 1. The effect of the MtrC hairpin on the vancomycin resist-
ance of Escherichia coli cells expressing MtrE.
Strain Vancomycin sensitivity (mm)
MtrE NI
MtrE/MtrC 9  1
MtrE E434K NI
MtrE E434K/MtrC NG
MtrE E434K/gIII-NT-MtrC NG
MtrE/gIII-Hairpin NI
MtrE E434K/gIII-Hairpin NI
MtrC/MtrD/MtrE NI
MtrC/MtrD/MtrE E434K 10  1
The indicated MtrE proteins were expressed from pACYC (and
pET21a) and the MtrC and hairpin, with an N-terminal gIII signal
sequence, proteins from pET24a in KAM3(DE3) E. coli cells in the
presence of 30 mg of vancomycin. The inhibitory zone diameter is
given in mm. All disc-diffusion assays were undertaken in triplicate
and the average result given. Abbreviations: NI, no inhibition of
growth; NG, no growth.
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The vancomycin MIC for these cells increased from 64 mg
ml-1 to 256 mg ml-1 when treated with 25 mM hexamine
cobalt. Presumably, because both HC and MtrD can block
the periplasmic end of the MtrE channel, they work
together to more effectively block vancomycin entry into
the cells.
Considering that the MtrC hairpin did not induce
opening of the channel of MtrE suggested that it might
have the potential to interfere with the assembly of the
pump by preventing the binding of full-length MtrC to
MtrE. However, we found that cells expressing MtrCDE
with the hairpin consistently grew better than those
expressing MtrCDE alone, in the presence of antibiotics;
while cells expressing the hairpin either alone, or with
MtrD, behaved as the control cells, which were sensitive
to antibiotics and grew poorly (Fig. S1). Furthermore, we
found that for the cells expressing the hairpin there was a
significant decrease in their susceptibility to a range of
antibiotics, and the cells were insensitive to vancomycin
(Table 2). These data clearly indicate that the hairpin inter-
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Fig. 2. Vancomycin entry into cells through MtrE is blocked by hexamminecobalt.
A. A homology model of the MtrE channel based upon a comparative sequence analysis of MtrE and TolC. This model demonstrates that
Asp371 and Asp374 in TolC, which form a binding site for hexamminecobalt (III) chloride (HC), are conserved in MtrE and exposed to the
internal channel cavity, thus likely forming a similar arrangement to that in TolC. The MtrE model is in blue; two subunits of the TolC–HC
complex (1TQQ.pdb) are in magenta; HC is in spacefill; residues Asp371 and Asp374 from TolC, and the homologous Asp422 and Asp425
from MtrE, are shown as sticks.
B. A series of curves showing the relative growth, measured as the OD600, for E. coli cells C43(DacrB) transformed with
pACYC-MtrC-MtrE(E434K) (left set of graphs) and pACYC-MtrC-MtrE(E434K) and pET21a-MtrD (right set of graphs). Cells were grown in the
absence of drugs (¥); or in the presence of HC (, 25 mM), vancomycin (, 6.4 mg ml-1), of HC and vancomycin (). Each bar is the average
of at least three measurements, with error bars representing the standard deviation of these measurements from the average. Cells
transformed with pACYC and pET grew slower than those transformed with pACYC only; but, as shown in the bar chart, attained a
comparable OD after overnight growth.
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acts with the pump, apparently activating it, rather than
preventing its assembly. Providing a plausible explanation
for this effect, chemical cross-linking, with EGS, revealed
that the hairpin forms heterologous dimers with NT-MtrC
(Fig. 3). Considering that there is mounting evidence that
the MFP forms dimers (Janganan et al., 2011b; Tikhonova
et al., 2011; Xu et al., 2011) that interact with three pairs of
intra- and inter-protomer grooves on the surface of the
surface of the trimeric OMP (Janganan et al., 2011b;
Ferrandez et al., 2012), our data can be rationalized if the
MFP binds to one of these grooves, while the hairpin
bindings to the other, to activate the pump. Indeed it is
expected that the two MFP-binding grooves on the
surface of the OMP will represent two different, degener-
ate binding interfaces with different affinities, something
that has also been previously suggested by ITC and SPR
Table 2. The effect of the MtrC hairpin on the antibiotic susceptibility of Escherichia coli cells expressing components of the MtrCDE multidrug
pump.
Constructs
Naf
1 mg
Tet
30 mg
Ery
10 mg
Nov
5 mg
Van
30 mg
pACYC-MtrCDE + pET24a 13  1 26  1 21  1 20  1 NI
pACYC-MtrCDE + pET24a-gIII MtrC hairpin 9  1 22  1 18  1 19  2 NI
pACYC + pET24a-gIII MtrC hairpin 20  1 36  1 30  0.1 20  1 NI
pACYC-MtrE 15  1 33  3 27  2 19  1 NI
pACYC-MtrE + pET24a-gIII MtrC hairpin 15  1 32  1 26  1 19  1 NI
pACYC MtrD 16  1 39  3 30  1 19  2 NI
pACYC MtrD + pET24a-gIII MtrC hairpin 15  1 40  2 30  1 20 + 1 NI
pACYC Vector + pET24a 18  2 35  2 32  3 21  1 NI
The indicated Mtr proteins were expressed from pACYC and the MtrC hairpin, with an N-terminal gIII signal sequence, from pET24a in KAM3(DE3)
E. coli cells. The inhibitory zone diameter is given in mm. All disc-diffusion assays were undertaken in triplicate and the average result given. The
amount of antibiotic impregnating each disc is given. Abbreviations: NI, no inhibition of growth; Naf, nafcillin; Tet, tetracycline; Ery, erythromycin;
Nov, novobiocin; Van, vancomycin.
Fig. 3. The hairpin of MtrC forms heterodimers with MtrC. To test for heterodimers of the MtrC hairpin with NT-MtrC, (1 mM) EGS was added
to (8 mM) MtrC hairpin mixed with (8 mM) NT-MtrC (lanes 7, 8 and 10) and analysed by SDS-PAGE. The control lanes are as follows:
Mr-standard (lanes 1 and 9), NT-MtrC (lane 2), hairpin (lane 3), NT-MtrC + EGS (lanes 4 and 5) and hairpin + EGS (lane 6). An arrow
indicates the bands corresponding to the formation of heterodimers of hairpin/NT-MtrC.
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binding assays (Janganan et al., 2011a,b; Tikhonova
et al., 2011). It is possible that while full-length MtrC is
needed to initiate opening of the MtrE channel, the hairpin
is capable of stabilizing the already open, activated state
of the channel, but it is clearly not capable of conveying
the opening on its own. Such data also agrees with the
idea of the OMP having two different affinity sites that
engage MFPs in a different fashion (Janganan et al.,
2011b; Tikhonova et al., 2011).
The dissociation of MtrD from MtrE requires energy that
is provided by proton translocation
Since our studies revealed that the C-terminal domain of
MtrC, which interacts with MtrD, is required to facilitate
opening of the MtrE channel, this suggested that it might
play a role in conveying conformational changes from
MtrD to MtrE. If this were the case, then presumably MtrD
would need to be functional to facilitate the opening of
MtrE. We sought to investigate this possibility by inacti-
vating MtrD and determining if it could support the
opening of MtrE. Previous studies of other RND pumps
have revealed three residues (e.g. D407 and D408 in
TMH 4, and K939 in TMH 10, of MexB; and the homolo-
gous D407, D408 and K939 residues of AcrB) that are
essential and proposed to function as part of the proton-
relay system (Guan and Nakae, 2001; Takatsuka and
Nikaido, 2006; Seeger et al., 2009). Bioinformatic analy-
sis indicates that the corresponding residues, D405, D406
and K948, are conserved in MtrD (Fig. S2), based on the
close homology of MtrD with both AcrB from E. coli
(48.3% identity) and MexB from Pseudomonas (48.6%
identity) respectively. The secondary structural elements
appear well preserved within the group as judged by
ALIGN (Cohen, 1997).
Accordingly, we chose these residues for mutagenesis,
with the aim of inactivating the pump. All of these residues
were found to be essential for MtrCDE conferred resist-
ance to antibiotics (Table 3). Furthermore, none of the
double or triple mutants appeared more sensitive than
any of the single mutants suggesting that they have a
concerted function, presumably in relaying protons across
the membrane (Eicher et al., 2009; Pos, 2009; Seeger
et al., 2009). To further confirm the hypothesis that these
residues could play a role of a proton-relay triad and are
colocalized in the MtrD, and taking advantage of the
number of high-resolution structures that are available for
these proteins, we generated two homology models of
MtrD, based on 2DHH.pdb (AcrB; Murakami et al., 2002)
and 2V50.pdb (MexB; Sennhauser et al., 2009) structures
respectively. When using the SSM superposition algo-
rithm of COOT (Emsley and Cowtan, 2004), the two inde-
pendent models align with a core RMSD of 2.3 Å, mainly
due to a few flexible loops and hairpins, and are overall
highly convergent, with the TM part in particular having an
RMSD of less than 1 Å (Fig. 4A). As can be seen in
Fig. 4A, in both models the residues are in close proximity
and likely interacting with each other. This allows for an
unambiguous location of the residues in the TM helices
and, as can be seen in Fig. 4B, the D405, D406 and K948
appear within bonding distance in both models. In combi-
nation with our biochemical data, this provides very strong
support to the idea of conservation of this charged
network across different RND transporters and suggests
that these residues perform in a similar fashion to those
previously established in AcrB.
In common with cells expressing wild-type MtrCDE, all
the mtrD mutants were insensitive to (discs impregnated
with 30 mg of) vancomycin (Table 4), and had an MIC of
512 mg ml-1, indicating that the MtrE channel is closed or
blocked. However, this behaviour could arise if, for the
mtrD mutants, MtrD became uncoupled from MtrCE. To
test for this possibility, we coexpressed the mtrD mutants
with mtrC/mtrE E434K. As noted above, while cells
expressing MtrC/MtrE E434K are sensitive to vancomycin
and fail to grow, we found that cells expressing MtrC/
MtrD/MtrE E434K are moderately sensitive (Table 4). If
MtrD was decoupled from MtrE E434K, in the cells
Table 3. Identification of MtrD mutations that impair the function of the MtrCDE pump.
Constructs
Tet
30 mg
Ery
10 mg
Nov
5 mg
Van
30 mg
pACYC MtrCE + pET21a MtrD WT 29  2 20  1 12  2 NI
pACYC MtrCE + pET21a MtrD D405K 40  1 30  1 17  1 NI
pACYC MtrCE + pET21a MtrD D406K 40  1 27  2 18  1 NI
pACYC MtrCE + pET21a MtrD K948E 40  1 27  2 19  1 NI
pACYC MtrCE + pET21a MtrD D405K/D406K 40  1 30  1 18  1 NI
pACYC MtrCE + pET21a MtrD D405K/D406K/K948E 40  2 30  2 19  1 NI
pACYC + pET21a 38  1 29  1 17  1 NI
The MtrCE proteins were expressed from pACYC and the MtrD derivatives from pET21a in KAM3(DE3) E. coli cells. The inhibitory zone diameter
is given in mm. All disc-diffusion assays were undertaken in triplicate and the average result given. The amount of antibiotic impregnating each
disc is given. Abbreviations: NI, no inhibition of growth; WT, wild-type; Tet, tetracycline; Ery, erythromycin; Nov, novobiocin; Van, vancomycin.
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expressing the mtrD mutants with mtrC/mtrE E434K, then
they should be highly sensitive to vancomycin and fail to
grow. Importantly, the cells can only become resistant to
vancomycin if they produce MtrD that can interact with
MtrC/E E434K to prevent MtrC unlocking the MtrE E434K
channel. Indeed, if MtrD failed to express at all, then the
cells would only produce MtrC/MtrE E434K, and would fail
to grow due to their sensitivity to vancomycin. Our analy-
sis revealed that cells expressing MtrD D405K, D406K
and/or K948E with MtrC/MtrE E434K were insensitive to
(discs impregnated with 30 mg of) vancomycin (Table 4),
and had an MIC of 512 mg ml-1. However, as expected,
the mutants were sensitive to a range of antibiotics that
are substrates of the pump (Table 4). Furthermore, pull-
down assays revealed that MtrC interacts with both MtrE
E434K and MtrD D405K/D406K/K948E, indicating that
the mutations in these proteins did not impair their ability
to interact (Fig. 5). These findings indicate that the MtrD
derivatives interact with MtrC and MtrE E434K resulting in
a seal of the MtrE channel. Consequently, access to the
lumen of the MtrE channel requires functional MtrD. Con-
sidering that the D405K, D406K and K948E derivatives of
Fig. 4. A homology model for MtrD.
A. An overlay of the MtrD models with AcrB trimer. The MexB-based model is in green; the AcrB-based model is in red; and the AcrB 2DHH
structure is shown as a light blue trimer. This figure was generated using Pymol.
B. This homology modelling allows for an unambiguous location of the residues in the TM helices, and as can be seen, D405, D406 and K948
(highlighted by a yellow circle) appear within bonding distance in both models. In combination with our biochemical data, this provides very
strong support to the idea of conservation of this charged network across different RND transporters and the clearly indicates that these
residues perform in a similar fashion to these previously established in AcrB.
Table 4. MtrD derivatives form a stable complex with MtrE, preventing vancomycin access into the cells.
Constructs
Naf
1 mg
Tet
30 mg
Ery
10 mg
Nov
5 mg
Van
30 mg
pACYC MtrCE + pET21a MtrD WT NI* 29  2 20  1 12  2 NI
pACYC MtrC/E (E434K) + pET21a MtrD WT NI* 45  1 40  1 21  1 10  1
pACYC MtrC/E(E434K) + pET21a MtrD D405K NI* 40  1 30  2 20  1 NI
pACYC MtrC/E(E434K) + pET21a MtrD D406K NI* 39  1 31  1 17  1 NI
pACYC MtrC/E(E434K) + pET21a MtrD K948E NI* 38  1 28  1 17  1 NI
pACYC MtrC/E(E434K) + pET21a MtrD (D405K/D406K) NI* 39  2 30  1 20  1 NI
pACYC MtrC/E (E434K) + pET21a MtrD (D405K/D406K/K948E) NI* 41  1 31  1 20  1 NI
pACYC + pET21a NI* 38  1 29  2 17  1 NI
pACYC 8  1 36  1 32  1 17  2 NI
pACYC MtrC/MtrE WT 24  1 36  1 37  1 21  1 9  1
pACYC MtrC/MtrE E434K NG 50  2 40  1 NG NG
The MtrCE proteins were expressed from pACYC and the MtrD derivatives from pET21a in KAM3(DE3) E. coli cells. The inhibitory zone diameter
is given in mm. All disc-diffusion assays were undertaken in triplicate and the average result given. The amount of antibiotic impregnating each
disc is given. Abbreviations: NI, no inhibition of growth; NI*, pET21a plasmid encoded resistance; WT, wild-type; Naf, nafcillin; Tet, tetracycline; Ery,
erythromycin; Nov, novobiocin; Van, vancomycin.
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MtrD are most likely compromised in their ability to trans-
locate protons, suggests that proton translocation is
coupled to exposure of the periplasmic end of the MtrE
channel, which is brought about by the dissociation of
MtrD from MtrE.
Discussion
Although our earlier studies provide strong evidence that
MtrC plays a role in controlling the activity of the pump by
binding to the intra- and inter-protomer grooves of MtrE,
what was not clear from such studies was whether binding
of the hairpin domain of MtrC is sufficient to induce opening
of the MtrE channel. Since our previous in vitro studies
revealed that the hairpin binds to both MtrE and its E434K
derivative (Janganan et al., 2011a); herein, we utilized a
gIII signal sequence to target the hairpin to the periplasm of
cells express MtrE E434K, revealing that the hairpin is
unable to unlock the MtrE channel on its own (Table 1).
This contrasts with full-length MtrC, or NT-MtrC targeted to
the periplasm with a gIII signal sequence, suggesting that
the C-terminal domain constrains the conformation of the
N-terminal hairpin domain, so that it can productively inter-
act with MtrE E434K to open its channel. The hairpin
domain is sandwiched between sequences that contribute
residues to the lipoyl, the b-barrel and the membrane
proximal (MP) domains, presumably restraining the flex-
ibility of the hairpin (Symmons et al., 2009). In the case of
AcrA, cross-linking studies have revealed that the
a-hairpin domain interacts with TolC (Lobedanz et al.,
2007), while the other three domains interact with AcrB
(Symmons et al., 2009). The crystal structure of AcrA
(Mikolosko et al., 2006), and molecular dynamic simula-
tions (MDS) (Wang et al., 2012), revealed that it has large
conformational flexibility that largely arises from the
relative motions between the a-hairpin and the other
domains. Interestingly, a G336C substitution in the MP
domain of AcrA inhibited the AcrABTolC pump, indicating
that interactions between this domain of AcrA and AcrB are
essential for the operation of the pump (Ge et al., 2009;
Tikhonova et al., 2011). Furthermore, while the AcrAB
complex cannot interact with a TolC derivative in which the
periplasmic end of the channel is open, a complex of AcrB
with the G336C derivative of AcrA can interact with this
open-state TolC derivative (Tikhonova et al., 2011), sug-
gesting that AcrAB interacts with the closed-state TolC and
that conformational changes in the MP domain of AcrA are
associated with opening of the TolC channel. It seems
highly plausible that the C-terminal end, and more pre-
cisely the MP domain, of the MFP is necessary for active
coupling and energy transduction from the IMP to the OMP.
Active proton translocation by the RND pump would
appear to result in the progressive peristaltic motion of the
pump (Murakami et al., 2006; Seeger et al., 2006; 2008),
which is propagated to the surface of the extrusion pro-
tomer (Seeger et al., 2008; Nakashima et al., 2011; Eicher
et al., 2012) and hence conceivably communicated to,
and resulting in equally dramatic conformational changes,
in the MFP. In turn, these conformational changes in the
MFP could be used to alter its interaction with the OMP; to
induce either opening of the OMP channel or the disen-
gagement of the MFP from the OMP, allowing the IMP/
MFP to dissociate from the OMP and hence decoupling of
the pump post-drug extrusion. To determine if MtrD com-
municates with MtrE, we produced a set of functionally
impaired mtrD mutants and tested the effect of these
derivatives on the MtrE channels ability to conduct van-
comycin. Cells expressing mtrC and mtrE E434K along
with the non-functional mtrD mutants were rendered
insensitive to vancomycin, as were cells expressing
mtrE E434K alone, while cells expressing mtrC and mtrE
E434K were highly sensitive to vancomycin (Table 4).
Fig. 5. MtrC binds to both MtrE E434K and MtrD D405K/D406K/K948E. The purified NT-MtrC GST-tagged protein was immobilized on GST
column beads, to which was added purified His-tagged MtrE E434K (B) or MtrD D405K/D406/K948E (A) prey protein. The beads were
washed with Tris buffer, containing 0.1% w/v bDDM, then boiled at 90°C for 5 min to elute the complex. Western blotting, using antibodies to
the His-tag, was used to detect the MtrE and MtrD prey proteins. As negative controls, either the bait protein or the prey protein was omitted
from the assay (the presence and absence of proteins is indicated by ‘+’ and ‘-’). As shown in each assay when either of these proteins was
omitted from the assay, the corresponding prey protein could not be detected. These assays indicate that MtrC interacts with MtrE E434K and
MtrD D405A/D406A/K948K.
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One possibility for this behaviour is that, while MtrC can
unlock the closed channel of MtrE E434K, the non-
functional MtrD derivatives interact with MtrC, preventing
it from unlocking the channel of MtrE E434K. However,
since the MtrD derivatives would not be expected to
undergo proton-driven conformational changes, it seems
unlikely that they could induce the closure of the MtrE
E434K channel, which would otherwise be open. An alter-
native, perhaps more plausible, possibility is that the MtrD
derivatives fail to disengage from MtrE E434K, effectively
sealing the channel to vancomycin entry. Such an intrigu-
ing interpretation would also suggest that channel unlock-
ing by the hairpins of MtrC is energy-independent, while
the proton-motive force is used to actively dissociate the
complex and re-seal the periplasmic end of MtrE. Consid-
ering that cells expressing MtrCDE E434K are sensitive to
vancomycin, which can be reversed by the binding of
hexamminecobalt to the periplasmic end of MtrE, implies
that MtrD can dissociate from MtrE E434K, which remains
in the open state; conversely, cells expressing MtrCDE
are insensitive to vancomycin, implying that the dissocia-
tion of MtrD is concomitant with closure of the MtrE
channel. The insensitivity of the cells expressing the non-
functional MtrD mutants to vancomycin would be consist-
ent with them failing to dissociate from MtrE E434K.
Indeed, in contrast to the substantive changes in the
conformation of the periplasmic domain of the wild-type
protein, there are only small changes in the conformation
of the periplasmic domain of the AcrB D407A, D408A
and K940A derivatives (Su et al., 2006; Takatsuka and
Nikaido, 2006; Nikaido and Takatsuka, 2009); conse-
quently, our MtrD derivatives would not be expected to
induce the substantive conformational changes in MtrC
that would presumably be necessary to induce its disen-
gagement from MtrE.
In summary, our studies utilizing MtrE E434K have
identified a number of additional conformational states
(Fig. 6A), which can be incorporated into a model for the
pump mechanism (Fig. 6B). The integral inner membrane
protein MtrD, presumably with bound drug, and MtrC form
a complex, in which a ring of six MtrC protomers assemble
around the MtrD trimer (state 1). This complex can then
dock with the MtrE trimer (state 2), which results in
opening of the secondary selectivity gate (the aspartate
ring) in the MtrE channel, but not the fully open state. The
docking of MtrE and MtrD promoted by MtrC leads to final
unlocking of the primary selectivity gate of MtrE by the
b-hairpins of MtrD, which has already been suggested for
TolC-AcrB (Andersen et al., 2002c; Tamura et al., 2005;
Bavro et al., 2008). We can only speculate at this stage on
the exact sequence of events during the engagement of
MtrC with MtrE, but similar to the AcrA/TolC interaction
(Bavro et al., 2008; Tikhonova et al., 2011), sequential
engagement of the intra- and inter-protomer grooves is
likely. Indeed it seems likely that the inter-protomer groove
becomes available only upon the initial binding of the first
MtrC monomer in the high-affinity intra-protomer groove,
and that this is associated with the disruption of the aspar-
tate gate, while the binding of the second hairpin, to the
low-affinity inter-protomer groove, is just to stabilize the
open assembly. Conceivably, the second hairpin only
engages with MtrE after it has bound to MtrD, to stabilize
the MtrE channel in the open conformation. The role of the
hairpin in unlocking of the aspartate gate can also be
implied by comparative studies of the Borellia efflux pump
BesABC (Bunikis et al., 2008), where the MFP BesA
uncharacteristically lacks a hairpin. It is notable however
that the corresponding second selectivity gate in the OMP
BesC is also not present. The binding of protons to the TM
domain of MtrD, and their subsequent passage through
the proton relay circuit, composed of the residues D405,
D406 and K948, induces conformational changes in the
periplasmic domain of MtrD that results in transfer of
bound drugs towards the periplasmic end of the MtrE
channel which has to be fully open by this stage (state 3).
The deep interpenetration of the MFP hairpins with the
helical coiled-coils of the TolC family members indicate
that this is likely a very stable interaction, which is further
confirmed by the fact that this extended binding interface
tolerates single mutations and from binding studies that
reveal a nanomolar affinity (Touzé et al., 2004; Bavro
et al., 2008; Tikhonova et al., 2009; 2011; Janganan et al.,
2011a,b). Furthermore, these interactions are about an
order of magnitude stronger than the corresponding IMP/
OMP interactions and are energy-independent (Touzé
et al., 2004; Janganan et al., 2011a; Tikhonova et al.,
2011). Dissociating such an extended binding interface is
likely to require energy, and it is clear that only the IMP
can provide this energy. In the absence of energy input,
the complex will stay associated permanently, which is
supported by our studies that suggest that vancomycin
entry is blocked by our inactivated MtrD derivatives, which
fail to dissociate from MtrE. Thus, this work provides a
tantalizing suggestion that there is at least one more
energy-dependent step in the drug expulsion process,
and that this is the dissociation of MtrC from MtrE (state
4). Our in vivo experiments of the interaction of MtrC with
MtrE E434K also clearly imply that MtrC is capable of
binding to MtrE in the absence of an energized pump,
which also results in channel opening. Thus the OMP–
MFP interaction appears to be energy-independent and
likely results in a low-energy state that is stabilized by the
extensive helical coiled-coils interfaces. Although it is
clear that MtrD must provide the energy for dissociation of
the MtrCDE tripartite complex, it is not known whether this
occurs concomitantly with drug extrusion. Once MtrC is
removed from MtrE, MtrD will be able to dissociate from
MtrE, and the outermost selectivity gate of MtrE will spon-
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taneously collapse, while MtrC and MtrD may remain
associated together for another drug cycle. It seems plau-
sible that the proton-driven conformational changes in
MtrD are coupled to conformational changes in MtrC that
trigger its dissociation from MtrE.
Experimental procedures
Strains and plasmids
The E. coli strains and plasmids used are described in
Table S1, and the primers used for construction of plasmid
vectors in Table S2. For in vivo studies of the effects of MtrC
and its hairpin upon MtrE and its E434 derivative, wild-type
and mutant mtrE were expressed from pACYC Duet, while
NT-mtrC and its hairpin, both bearing a gIII signal sequence
to target the proteins to the periplasm, were expressed from
pET24a. These experiments were also repeated using (i)
pACYC Duet to express both mtrE and mtrC/gIII-hairpin, and
(ii) pET21a and pET24a to express mtrE and mtrC/gIII-
hairpin respectively. Such studies confirmed that the resulting
effects were independent of the vector pair used for coex-
pression of these proteins (data not shown). For in vivo
studies of the effect of introducing mutations into mtrD, the
pET21a-mtrD plasmid was used as the template for site-
directed mutagenesis using a QuikChange XL kit from Strata-
gene, with the primers given in Table S3.
Fig. 6. A schematic model for the assembly and function of the MtrCDE tripartite pump.
A. Additional conformational states for assemblies of the components of the MtrCDE tripartite pump identified using the E434K, vancomycin
leaky, derivative of MtrE. In the case of the MtrE E434K derivative, both the primary and the secondary gates of the channel are open, so that
it can leak vancomycin. However, MtrD is capable of sealing the channel, to prevent vancomycin entry, until it dissociates from MtrE E434K.
B. A schematic model for the action of the MtrCDE pump. MtrC and MtrD form a complex (state 1) that in response to drug binding interacts
with MtrE (state 2). The binding of MtrC to the intra and inter-protomers grooves, and then of MtrD, to the periplasmic tip, of MtrE opens the
secondary and primary gates, respectively, of the MtrE channel. The binding of protons to the membrane domain of MtrD induces
conformational changes in the periplasmic domain of MtrD that results in transfer of bound drugs to the open MtrE channel (state 3). A further
energy-dependent step, possibly involving a second proton translocation event, is then needed to drive the dis-engagement of MtrCD from
MtrE (state 4), allowing MtrE to collapse back to its original closed conformation (state 1). The protomers are labelled P1 and P2 (while P3 is
hidden from view). The movement pathway of the drug (blue hexagon) and the proton (red circle) is shown as a red curved arrow; while that
the sequential binding (marked 1 and 2) of the MtrC hairpin domains to the intra- and inter-protomers grooves of MtrE as yellow curved
arrows.
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Protein overexpression and purification
The MtrD, MtrE, NT-MtrC and MtrC hairpin proteins were
purified as fusion proteins with a six-histidine tag, while GST-
tagged NT-MtrC was used for pull-down assays. E. coli cells
[strain BL21(DE3) transformed with the relevant pET21a
vector for expression MtrD, MtrE, NT-MtrC and MtrC hairpin
proteins] were grown at 37°C in 2¥ YT media, with shaking at
220 r.p.m., until the cells density reached an A600 of 0.6, when
0.5 mM IPTG was added, the temperature adjusted to 25°C
and cells left to overexpress proteins for 6 h for membrane
proteins and 3 h for soluble proteins. Cells were harvested by
centrifugation at 4°C and resuspended in 20 mM Tris-HCl
buffer, 300 mM NaCl, pH 7.5, 10% v/v glycerol. Complete
protease inhibitor (Roche) and DNase I (Sigma) was added to
the cell paste before lysing the cells, via three passes (e.g.
1 ¥ 10 kpsi and 2 ¥ 25 kpsi) using a (Z-plus 1.1 kW) Constant
Systems cell disrupter. Cell debris was removed by centrifu-
gation at 37K g (45 min at 4°C), and cell membranes isolated
by ultracentrifugation at 125K g (90 min at 4°C) for membrane
proteins, while the supernatant was collected for soluble pro-
teins. Membranes pellets were then solubilized in 20 mM
Tris-HCl buffer, pH 7.5, 100 mM NaCl, 10% (v/v) glycerol, 2%
w/v b-D-dodecyl maltoside (bDDM) (Anatrace). For the purifi-
cation of MtrD and MtrE proteins the membranes pellets were
dissolved in 2% w/v bDDM and the protein were purified under
0.1% w/v bDDM by affinity chromatography using a Ni2+-
charged HiTrap chelating column (GE Healthcare). After
desalting, samples were subjected to ion exchange chroma-
tography, using either a (GE Healthcare) HiTrap Q or a SP
column, for the MtrD and MtrE proteins respectively, which
were eluted using a NaCl gradient. For the purification of
His-tagged D1–34-MtrC (NT-MtrC) and 100–183 a-helical
hairpin of MtrC, the supernatant was purified by affinity chro-
matography using a HiTrap Ni2+-chelating column, followed by
gel filtration chromatography, using a 120 ml Hiload 16/600
Superdex 200 prep grade column, in 20 mM Tris-HCl buffer,
pH 7.5, 300 mM NaCl, 10% v/v glycerol. In addition, we found
that the hairpin could be purified from cells that had been
subjected to an osmotic shock to release periplasmic proteins:
confirming the presence of the hairpin in the periplasm. For the
purification of GST-tagged NT-MtrC, the protein was overex-
pressed by growing the E. coli cells [strain BL21(DE3) trans-
formed with pGEX6p-3-NT-MtrC] at 25°C overnight with
0.2 mM IPTG. After cell lysis (in PBS) and centrifugation at
37K g (30 min at 4°C), the supernatant was mixed with GST
resin and incubated at 4°C for 30 min. Then the resin was
packed into a gravity flow column, washed with PBS and finally
eluted with 10 mM glutathione (in PBS). The eluted protein
was concentrated (to give a volume of about 3 ml) using a
50 kDa cut-off Vivaspin concentrator, and loaded onto a gel
filtration column (Hiload 16/600 Superdex 200) for further
purification.
Disc diffusion assays
Escherichia coli cells [strain KAM3(DE3) (Mima et al., 2007)]
were grown to an OD600 of about 0.5, induced with 0.1 mM
IPTG, the cells were diluted to an OD600 of 0.3 and then 350 ml
of cell culture was spread on an MHA plate previously incor-
porated with 0.1–0.2 mM IPTG; antibiotic discs were placed
on the plate medium and incubated at 37°C overnight. The
zone of culture growth inhibition was determined. The discs
used were impregnated with 1 mg of nafcillin, 30 mg of tetra-
cycline, 10 mg of erythromycin, 5 mg of novobiocin and 30 mg
of vancomycin. Western blotting with protein sequence-
specific antibodies and/or antibodies to the His-tag was rou-
tinely used to test the cells used for antibiotic sensitivity
assays for the expression of the MtrC, MtrD and MtrE pro-
teins. None of the mutants used in our studies had protein
levels substantively different than found in cells expressing
the wild-type proteins; and consequently the differences in
antibiotic sensitivity are not attributable to differences in the
protein expression levels.
Growth curve assays
Escherichia coli cells (DacrB strains KAM3 or C43) were grown
at 37°C in LB, supplemented with 30 mg ml-1 chloramphenicol,
for selection of pACYC, and/or 100 mg ml-1 carbenicillin, for
selection of pET, to an OD600 of about 0.4, and then induced
with 1 mM IPTG for 2–2.5 h at 37°C. The cells were diluted to
an OD600 of about 0.1, with LB, supplemented with appropriate
antibiotics (e.g. 30 mg ml-1 chloramphenicol and/or 100 mg ml-1
carbenicillin) and for some cultures hexammine cobalt (III)
chloride (final concentration 25 mM) and/or vancomycin (final
concentration 6.4 mg ml-1), and the cells grown at 37°C, while
recording their OD every 30 min, until they reached stationary
phase. Similarly, after IPTG induction, the cells were diluted
with 2¥ YT media containing antibiotic and monitored for
growth after 24 h for MIC measurements.
Pull-down assays
For pull-down assays, we used the GST-tagged NT-MtrC as
the bait protein, to pull-down the His-tagged MtrD and MtrE
prey proteins. The purified NT-MtrC GST-tagged protein was
immobilized on GST column beads (GE Healthcare), to which
was added purified His-tagged MtrE E434K or MtrD D405K/
D406/K948E prey protein (5 mg protein in 0.5 ml). The beads
were washed with Tris buffer, containing 0.1% w/v bDDM,
and then boiled at 90°C for 5 min to elute the complex. The
proteins in samples were run on an SDS-PAGE gel and
Western blotting was performed, with antibodies to the His-
tag, to detect if the MtrD and MtrE prey proteins were present
in the samples. Furthermore, the samples were subjected to
MALDI-ToF PMF analyses, performed using a Voyager-DE™
STR BioSpectrometry™Workstation (Applied Biosystems,
Warrington, UK). De-isotoped and calibrated spectra were
then used to generate peak lists, which were searched using
MASCOT (http://www.matrixscience.com) mass spectrom-
etry database search software to identify the proteins. As a
control, the GST protein was immobilized on GST column
beads and tested for any interaction with the His-tagged prey
proteins. No interaction of the His-tagged MtrD and MtrE prey
proteins with GST was detected (data not shown).
Cross-linking of MtrC and hairpin
NT-MtrC and MtrC hairpin proteins were first buffer
exchanged with Na2HP04, 100 mM NaCl, 10% v/v glycerol
and 1 mM EDTA using mini chromatography column (Bio-
RAD): 8 mM of each protein was incubated with 1 mM ethyl-
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ene glycol bis-succinimidyl-succinate (EGS) at room
temperature for 1 h. Then the cross-linking reaction was
stopped with 100 mM Tris HCl, the sample was reduced with
50 mM DTT and mixed with 4¥ LDS sample buffer, boiled at
100°C for 10 min and separated on a 4–12% SDS-PAGE
gradient gel with MOPS buffer.
Homology modelling of MtrE and MtrD
The homology model for MtrE has previously been reported
(Janganan et al., 2011a,b). Two independent homology
models of MtrD were created using ESyPred3D (Lambert
et al., 2002) and utilizing the MODELLER (Sali and Blundell,
1993) homology-modelling engine based on the high-
resolution experimental structures of AcrB (2DHH.pdb) and
MexB (2V50.pdb) respectively. Models were superposed and
analysed using Coot (Emsley and Cowtan, 2004) and struc-
tural alignments executed with Espript (Gouet et al., 1999).
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